Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Whitney Tilson’s Small Cap dELiA*s (DLIA) Investment

As of September 30, 2010, Whitney Tilson’s hedge fund T2 Partners had over 2.75% of its long equity portfolio in small-cap specialty retailer dELiA*s (NASDAQ: DLIA). In fact, the company is so small that Tilson’s nearly $6 million position accounts for almost 10% of the company’s outstanding shares. At the close of trading on Thursday, DLIA had a market cap of just $62 million. While the last available 13-F for T2 discloses positions held at the end of September, there is no reason to believe that Tilson has divested, although he certainly could have. Either way, it certainly appears that the opportunity in DLIA is still very attractive.


At first glance, it might sound crazy that a prominent hedge fund manager like Tilson would be speculating in a penny stock like DLIA. Once you examine the numbers, however, it becomes obvious. You see, Tilson is a value manager to the core and based on his DLIA position, it is pretty obvious that he will pursue value no matter where he finds it. DLIA is trading well below book value, or what the company would fetch if it were liquidated. The shares are trading at $1.98 with a book value per share of $2.69.

Furthermore, dELiA*s has no long term debt and has grown its annual revenues each of the past five years. At the beginning of 2007, this was a $10 stock. While management has had a very difficult time executing in the current environment, notching a near $10 million net loss in the most recent quarter, this still remains a tremendous opportunity. The risk/reward in this name appears to be quite asymmetrical. On the one hand, DLIA has the potential upside of a speculative stock in that it is a small-cap company experiencing near-term operational problems whose stock price could soar if the company is able to return to profitability. On the other hand, DLIA is a deep value name with a large margin of safety. At current levels, investors can still be reasonably certain that they will get their money back even if the company were to liquidate tomorrow.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!